HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2- (4- chlorophenyl)- 2,5- dihydropyrazolo(4,3- c)quinoline- 3(3H)- one

inhibits binding of benzodiazepine cpds to benzodiazepine receptors in the brain
Also Known As:
CGS 9896; CGS-9896; 3H-Pyrazolo(4,3-c)quinolin-3-one, 2-(4-chlorophenyl)-2,5-dihydro-
Networked: 11 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Aichholz, Reiner: 1 article (03/2011)
2. Blanz, Joachim: 1 article (03/2011)
3. Hintermann, Samuel: 1 article (03/2011)
4. Hurth, Konstanze: 1 article (03/2011)
5. Kaupmann, Klemens: 1 article (03/2011)
6. Mosbacher, Johannes: 1 article (03/2011)
7. Nozulak, Joachim: 1 article (03/2011)
8. Tintelnot-Blomley, Marina: 1 article (03/2011)

Related Diseases

1. Seizures (Absence Seizure)
2. Hyperphagia (Overeating)
3. Ataxia (Dyssynergia)
4. Ulcer
5. Stomach Ulcer (Gastric Ulcer)

Related Drugs and Biologics

1. GABA-A Receptors (GABA(A) Receptor)
2. Anticonvulsants (Antiepileptic Drugs)
3. Pentylenetetrazole (Metrazol)
4. Ligands
5. Benzodiazepines
6. ZK 91296
7. Oxygen (Dioxygen)
8. Hypnotics and Sedatives (Sedatives)
9. Flunitrazepam (Rohypnol)
10. Diazepam (Valium)